Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Nov. 27, 2020, 4:45 p.m. EST

Moderna Inc. stock outperforms competitors on strong trading day

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA climbed 16.35% to $127.03 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.92% to 12,205.85 and the Dow Jones Industrial Average DJIA rising 0.13% to 29,910.37. This was the stock's second consecutive day of gains. Moderna Inc. hit a new 52-week high, surpassing its previous peak of $109.29, which the company reached on November 25th.

The stock outperformed some of its competitors Friday, as AbbVie Inc. ABBV rose 0.66% to $104.89, Amgen Inc. AMGN rose 2.04% to $224.81, and AstraZeneca PLC ADR AZN rose 0.02% to $52.61. Trading volume (43.4 M) eclipsed its 50-day average volume of 10.7 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.